SCHEMBL3940604

SCHEMBL3940604

O=C(O)NCCC1CCN(CCc2ccccc2Cl)CC1

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.52
ACHE P22303 1/20 0.51
CHRM4 P08173 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3942415 0.82 CHRM4 (0.48) ACHECHRM4
SCHEMBL2981989 0.81 KCNH2 (0.46) KCNH2ACHECHRM4
SCHEMBL3945816 0.81 CXCR4 (0.59) ACHECHRM4
SCHEMBL5709511 0.80 SIGMAR1 (0.60) KCNH2
SCHEMBL3946467 0.79 ACHE (0.52) ACHECHRM4
SCHEMBL3937456 0.77 CHRM4 (0.68) ACHECHRM4
SCHEMBL3937725 0.76 MAOA (0.52) ACHECHRM4
SCHEMBL3936620 0.76 HTR2A (0.56) CHRM4
SCHEMBL3597886 0.75 CXCR4 (0.71)
SCHEMBL3939238 0.74 CHRM4 (0.53) ACHECHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720550-B1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI AVENTIS (FR) 2009-04-15 EP claimed
EP-1720550-B1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI AVENTIS (FR) 2009-04-15 EP disclosed
EP-1720550-A1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS Sanofi-Aventis (FR) 2006-11-15 EP disclosed
WO-2005089759-A1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2005-09-29 WO disclosed